Altogether, we uncover that both pharmacological and siRNA‐mediated VPS34 inhibition in RCC and melanoma cells activates the type I IFN and proinflammatory cytokine response via induction of the cGAS‐STING pathway. Here, CGAS is linked to melanoma.